U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Guidance for Industry: The Seafood List FDA’s Guide to Determine Acceptable Seafood Names
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

Guidance for Industry: The Seafood List FDA’s Guide to Determine Acceptable Seafood Names August 2023

Download the Final Guidance Document Read the Federal Register Notice
Final
Docket Number:
FDA-1994-D-0221
Issued by:
Guidance Issuing Office
Human Foods Program

This guidance is intended to provide guidance to industry about what FDA considers to be acceptable market and common names for seafood sold in the United States and to help manufacturers in labeling seafood products.  This guidance provides more information on the acceptable market name, common name, scientific name, and vernacular name of seafood species sold in the United States.  These names are listed in FDA’s guide entitled The Seafood List.

FDA’s guidance documents, including this guidance, do not establish legally enforceable responsibilities.  Instead, guidances describe our current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited.  The use of the word should in FDA guidance documents means that something is suggested or recommended, but not required.

Download the Guidance

The FDA Seafood List - Recent Updates and Additions

Related Information

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-1994-D-0221.

Back to Top